Zhejiang Qianjiang Biochemical Co., Ltd (600796.SS)
- Previous Close
5.70 - Open
5.70 - Bid 5.64 x --
- Ask 5.65 x --
- Day's Range
5.63 - 5.75 - 52 Week Range
3.88 - 9.30 - Volume
4,280,000 - Avg. Volume
7,840,378 - Market Cap (intraday)
4.896B - Beta (5Y Monthly) 0.42
- PE Ratio (TTM)
29.74 - EPS (TTM)
0.19 - Earnings Date --
- Forward Dividend & Yield 0.03 (0.55%)
- Ex-Dividend Date Jun 27, 2024
- 1y Target Est
--
Zhejiang Qianjiang Biochemical Co., Ltd. develops, produces, and sells biopesticide and veterinary drugs, and biological medicine intermediates in China. The company provides biopesticide products comprising validamycin, gibberellic acid, abamectin, methylamino abamectin, and other products; biological drugs, including colistin sulfate premix and colistin sulphate; biological drugs intermediates; and feed additives. It also offers external heating services. The company exports its products to the United States, West Europe, South America, and Southeast Asia. Zhejiang Qianjiang Biochemical Co., Ltd. was founded in 1970 and is based in Haining, China.
www.qianjiangbioch.com2,021
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 600796.SS
View MorePerformance Overview: 600796.SS
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600796.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600796.SS
View MoreValuation Measures
Market Cap
4.90B
Enterprise Value
6.50B
Trailing P/E
29.74
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.68
Price/Book (mrq)
1.48
Enterprise Value/Revenue
3.67
Enterprise Value/EBITDA
25.85
Financial Highlights
Profitability and Income Statement
Profit Margin
9.13%
Return on Assets (ttm)
1.48%
Return on Equity (ttm)
3.63%
Revenue (ttm)
1.77B
Net Income Avi to Common (ttm)
161.73M
Diluted EPS (ttm)
0.19
Balance Sheet and Cash Flow
Total Cash (mrq)
820.9M
Total Debt/Equity (mrq)
72.52%
Levered Free Cash Flow (ttm)
-641.25M